Spyre Therapeutics, Inc. (SYRE)

43.21 +5.40 (+14.28%) USD  |  NASDAQ  |  Feb 20, 16:00
43.80 +0.59 (+1.37%) After-Hours: 20:00
More

Spyre Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade